The Patent Finder

Biovail Laboratories Inc.

Also on record
Records under this name other than patents Biovail Laboratories Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Biovail Laboratories Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,241,805Modified Release Formulations of a Bupropion Salt
Held by another company
Term ended
Term ended Jun 27, 2026 · High confidence
Term endedTerm ended Jun 27, 2026High confidence
US 7,780,987Controlled Release Dosage Forms
Formerly held
Term ended
Term ended Mar 23, 2025 · High confidence
Term endedTerm ended Mar 23, 2025High confidence
US 7,537,784Modified Release Tablet of Bupropion Hydrochloride
Formerly held
Term ended
Term ended Jun 5, 2024 · Medium confidence
Term endedTerm ended Jun 5, 2024Medium confidence
US 6,338,857Sustained release carbamazepine pharmaceutical composition free of food effect and a method for alleviating food effect in drug release
Formerly held
Term ended
Term ended May 26, 2020 · USPTO record
Term endedTerm ended May 26, 2020USPTO record
US 8,128,957Modified Release Compositions of at Least One Form of Tramadol
Formerly held
Lapsed on the fee record
Ended Mar 6, 2020 · Low confidence
Lapsed on the fee recordEnded Mar 6, 2020Low confidence
US 7,108,866Chronotherapeutic diltiazem formulations and the administration thereof
Formerly held
Term ended
Term ended Dec 17, 2019 · USPTO record
Term endedTerm ended Dec 17, 2019USPTO record
US 6,143,327Delayed release coated tablet of bupropion hydrochloride
Formerly held
Term ended
Term ended Dec 13, 2019 · USPTO record
Term endedTerm ended Dec 13, 2019USPTO record
US 6,033,686Controlled release tablet of bupropion hydrochloride
Formerly held
Term ended
Term ended Oct 30, 2018 · USPTO record
Term endedTerm ended Oct 30, 2018USPTO record
US 6,096,341Delayed release tablet of bupropion hydrochloride
Formerly held
Term ended
Term ended Oct 30, 2018 · USPTO record
Term endedTerm ended Oct 30, 2018USPTO record
US 6,967,218Pravastatin Pharmaceutical Formulations and Methods of Their Use
Formerly held
Lapsed on the fee record
Ended Nov 22, 2017 · High confidence
Lapsed on the fee recordEnded Nov 22, 2017High confidence
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited